Ocean Biomedical Stock Today
| OCEA Stock | 0.06 0 2.54% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Ocean Biomedical is trading at 0.0605 as of the 19th of March 2025, a 2.54% up since the beginning of the trading day. The stock's open price was 0.059. Ocean Biomedical has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of November 2021 | Category Healthcare | Classification Health Care |
Ocean Biomedical is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 34.65 M outstanding shares of which 754.28 K shares are now shorted by private and institutional investors with about 2.64 trading days to cover. More on Ocean Biomedical
Moving together with Ocean Stock
Moving against Ocean Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Ocean Stock Highlights
| CEO Director | Elizabeth MBA | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology & Medical Research, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsOcean Biomedical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ocean Biomedical's financial leverage. It provides some insight into what part of Ocean Biomedical's total assets is financed by creditors.
| |||||
Ocean Biomedical (OCEA) is traded on NASDAQ Exchange in USA. It is located in 55 Claverick Street, Providence, RI, United States, 02903 and employs 8 people. Ocean Biomedical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 25.64 M. Ocean Biomedical conducts business under Biotechnology sector and is part of Health Care industry. The entity has 34.65 M outstanding shares of which 754.28 K shares are now shorted by private and institutional investors with about 2.64 trading days to cover.
Ocean Biomedical generates negative cash flow from operations
Check Ocean Biomedical Probability Of Bankruptcy
Ownership AllocationOcean Biomedical owns a total of 34.65 Million outstanding shares. Ocean Biomedical holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 71.98 pct. of Ocean Biomedical outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Ocean Ownership Details
Ocean Biomedical Historical Income Statement
Ocean Stock Against Markets
Ocean Biomedical Corporate Executives
Elected by the shareholders, the Ocean Biomedical's board of directors comprises two types of representatives: Ocean Biomedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ocean. The board's role is to monitor Ocean Biomedical's management team and ensure that shareholders' interests are well served. Ocean Biomedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ocean Biomedical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gurinder MBA | CFO Treasurer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocean Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.